Cargando…
Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review
The development of remdesivir has been a breakthrough for COVID-19 treatment. It has been approved in about 50 countries, including Saudi Arabia, since 2020. The generic structure of remdesivir was first disclosed in 2009. This patent review summarizes the remdesivir based inventions to treat/preven...
Autores principales: | Imran, Mohd., Alshrari, Ahmed Subeh, Asdaq, Syed Mohammed Basheeruddin, Abida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236076/ https://www.ncbi.nlm.nih.gov/pubmed/34243049 http://dx.doi.org/10.1016/j.jiph.2021.06.013 |
Ejemplares similares
-
The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature
por: Imran, Mohd, et al.
Publicado: (2022) -
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
por: Imran, Mohd., et al.
Publicado: (2021) -
Innovations and development of Covid-19 vaccines: A patent review
por: Alshrari, Ahmed S., et al.
Publicado: (2022) -
Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades
por: Imran, Mohd., et al.
Publicado: (2021) -
Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature
por: Imran, Mohd, et al.
Publicado: (2022)